The relationship between blood pressure changes and the efficacy of treatment in patients with primary glomerulonephritis with special regard to kidney size by Marcinkowska, Elżbieta & Manitius, Jacek
16 www.ah.viamedica.pl
ORIGINAL PAPER
Address for correspondence: Elżbieta Marcinkowska, MD, PhD, „Nowy Szpital” Spółka z o.o. z siedzibą w Szczecinie
Stacja Dializ „Nowy Szpital” w Świeciu ul. Wojska Polskiego 126, 86–100 Świecie, Polska
tel./fax: +48 41 240 1677, e-mail: elama@wp.pl 
Copyright © 2018 Via Medica, ISSN 2449–6170
The relationship between blood pressure 
changes and the efficacy of treatment in 
patients with primary glomerulonephritis with 
special regard to kidney size
Elżbieta Marcinkowska1, Jacek Manitius2
1“Nowy Szpital” Spółka z o.o. with registered office in Szczecin, Hemodialysis Unit in Świecie, Poland 
2Department of Nephrology, Hypertension and Internal Diseases, Nicolaus Copernicus University in Toruń, Ludwik Rydygier Collegium Medicum  
in Bydgoszcz, Poland
Abstract
Introduction. Blood pressure plays a modulating role in the progression of glomerulonephritis. Kidney size could 
also constitute a factor influencing the efficacy of treatment. 
The study sought to determine renal length and the influence of blood pressure changes and renal length on the 
efficacy of treatment.
Material and methods. This study included 53 adult patients (25 female and 28 male), aged 17 to 63. At the be-
ginning of the observation period, the following tests were performed: percutaneous renal biopsy, anthropometric 
measurements, renal length in abdominal ultrasound scan. At the beginning of the observation period and after 
24 months the following tests were performed: SBP, DBP, MAP, PP, serum creatinine level, GFR MDRD, DPL. 
Absolute renal length (D) was related to anthropometric parameters and values of relative renal length D/H, 
D/BSA, D/BMI were calculated. 
Results. D value ranged from 93.5 mm to 135.5 mm. Mean values of parameters were: D/H 0.67 ± 0.07 mm/cm, 
D/BSA 61.8 ± 8.7 mm/m2, D/BMI 4.67 ± 0.79 mm/kg/m2. No correlations were found of DPL changes and GFR 
MDRD changes with arterial pressure. A correlation was found between DPL changes and D. In patients whose 
DPL values decreased by at least 50%, mean values of D, D/H and D/BSA were higher. No correlations were found 
of GFR MDRD changes with D, D/H, D/BSA or D/BMI.
Conclusions. No influence of arterial blood pressure on the efficacy of treatment was discovered. Renal length is not 
a prognostic factor for changes in glomerular filtration rate; however, it can be a prognostic factor for proteinuria 
changes.
Key words: blood pressure, body mass index, body surface area, glomerular filtration rate, glomerulonephritis, 
height, proteinuria, renal length.
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Abbreviations: ACEI — angiotensin-converting 
enzyme inhibitors; ARB — angiotensin receptor 
blockers; b.w. — body weight; BMI — body mass 
index; BSA — body surface area; CKD — chronic 
kidney disease; D — absolute renal length; DBP — 
diastolic blood pressure; DPL — daily protein loss 
in urine; GFR MDRD — glomerular filtration rate 
according to MDRD formula; H — height; MAP 
— mean arterial pressure; NPG — non-proliferative 
glomerulonephritis; PG — proliferative glomerulo-
nephritis; PP — pulse pressure; RAA — renin-an-
giotensin-aldosterone system; SBP — systolic blood 
pressure 
Background
In patients with primary, chronic glomerulopathies, 
immune processes causing damage to the glomerular 
filtration barrier manifest themselves in proteinuria 
and glomerular filtration defect, and induce the de-
velopment of secondary, renal parenchymal hyper-
tension [1–3].
Apart from the underlying, causal immune pro-
cess, proteinuria and glomerular filtration defect are 
also affected by intraglomerular pressure and he-
modynamic conditions within the renal glomeruli 
affected by, among other things, systemic arterial 
pressure [2].
The progressive decrease in the number of ac-
tive nephrons further propels the vicious cycle by 
worsening hemodynamic disorders in the remaining, 
normally-functioning nephrons, leading to the ag-
gravation of proteinuria and its negative consequen-
ces, i.e. further progression of glomerular filtration 
defect. An important modulatory role in this process 
is played by arterial blood pressure [4, 5].
The progressive loss of active nephrons ultimately 
results in reduced kidney size and altered kidney 
structure [6, 7]. One of kidney size parameters is 
renal length, that is the measurement of its longitu-
dinal axis obtained by measuring the longest straight 
line between two visible poles of the kidney [8]. Re-
nal length constitutes an indicator of the progression 
of histopathological changes and chronicity of the 
disease process, as well as renal functional status and 
reserve [9–11].
Calculating relative renal length by relating abso-
lute renal length to such anthropometric parameters 
as height, body surface area (BSA) and body mass 
index (BMI) serves as an attempt to determine no-
mograms and standardize kidney size, which would 
allow for the objectivization of the progression of 
structural changes.
It could be assumed that renal length could consti-
tute a prognostic factor, modifying the extent of the 
influence of arterial pressure changes on the efficacy 
of treatment.
It thus seems reasonable to carry out an investiga-
tion aiming at:
1. Determining the absolute and relative renal 
length.
2. Assessing the influence of blood pressure changes 
and absolute and relative renal length on the effi-
cacy of treatment.
3. Determining whether renal length modifies the 
influence of blood pressure changes on treatment 
efficacy.
4. Determining whether the type of glomerulone-
phritis has any bearing on the influence of blood 
pressure and renal length on treatment efficacy.
The study analyzed two indicators of the efficacy 
of treatment in a two-year period of observation: re-
duction of proteinuria and decline of renal excretory 
function.
Material and methods
The study was conducted retrospectively by analyz-
ing medical records of patients with primary, chronic 
glomerulonephritis, diagnosed and treated at the De-
partment of Nephrology, Hypertension and Internal 
Diseases and at the Outpatient Clinic of Nephrology 
of the Antoni Jurasz University Hospital in Byd-
goszcz, in the years 2000–2006. 
The study protocol was approved by The Bioethics 
Committee at Collegium Medicum in Bydgoszcz 
(KB/81/2007). 
The study included patients over 17 years of age 
with complete clinical records, from whom representa-
tive material for histopathological testing was obtained, 
that is no less than 5 glomeruli in kidney specimens 
collected for analysis under an optical and immuno-
fluorescence microscope, and whose two-year period 
of observation following renal biopsy was completed.
Initial analysis was performed in all patients who 
underwent renal biopsy in the years 2000–2004 (180 
patients in total). After the analysis of the clinical 
course of kidney disease and kidney biopsy results, 
patients with the following conditions were excluded 
from further study:
 — diabetes (irrespective of histopathological test re-
sults),
 — secondary glomerulopathies in the course of col-
lagenosis, including SLE, systemic vascular in-
flammation, neoplastic diseases, chronic inflam-
matory states,
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 — glomerulopathies in the course of diabetes, amy-
loidosis,
 — hypertensive nephropathy,
 — acute and rapidly progressive glomerulopathies.
Ultimately, 53 patients were involved in the study, 
including 25 women and 28 men. The patients were 
aged 17 to 63; mean age was 37.6 ± 12.9.
Analysis of medical reports pertained to the period 
of two weeks before and two weeks after renal biop-
sy, which was taken as the beginning of observation 
(„0”), and at twenty-four months („24”) following 
renal biopsy.
At the beginning of observation („0”), the fol-
lowing procedures were performed: percutaneous 
renal biopsy, measurement of body weight (b.w.) 
and height (H) and subsequent calculation of BSA 
and BMI, and determination of right and left kidney 
length performed upon revealing the longitudinal 
cross-section and axis of the kidneys in abdominal 
ultrasound examination. For each patient, absolute 
renal length (D) was calculated as the arithmetic 
mean of right and left kidney length.
BSA (m2) = 0.007184 × b.w.0.425 × H0.725 [12]
BMI (kg/m2) = b.w./H2
where:
b.w. — body weight [kg],
H — height [m].
Absolute renal length (D) was related to anthropo-
metric parameters by calculating the measurements 
of relative renal length D/H, D/BSA, D/BMI.
Based on renal biopsy, PG was diagnosed in 32 
(60.4%) patients, and NPG in 21 (39.6%) patients 
(Figure 1).
At „0” and at ,,24”, the following parameters were 
measured: SBP and DBP, which were the basis for 
calculation of MAP and PP, and serum creatinine 
level, which was the basis for calculation of GFR 
MDRD and DPL.
MAP (mmHg) = DBP + 1/3 × (SBP–DBP) 
PP (mmHg) = SBP–DBP
GFR MDRD (mL/min/1.73 m2) = 186 × (serum 
creatinine)-1.154 × (age)-0.203 × C
where: 
C — constant value: for men — 1; for women — 
0.742; for African Americans — 1.21 [13].
Arterial hypertension was diagnosed in 37 
(69.8%) out of 53 patients: 20 (71.4%) out of 28 
men and 17 (68.0%) out of 25 women; 23 (71.9%) 
out of 32 patients with PG and 14 (66.7%) out of 21 
patients with NPG. The differences were statistically 
insignificant.
During the two-year observation period, the pa-
tients were treated with immunosuppressive and 
antihypertensive drugs, in accordance with recom-
mended treatment protocols. Target values of arterial 
pressure were the lowest ones, well tolerated by the 
patients. During the observation period, ACEI drugs 
were administered to 46 (86.8%), ARB drugs — to 
16 (30.2%), and ACEI and ARB simultaneously 
— to 14 (26.4%) out of 53 patients. Despite no 
prior hypertension diagnosis, 14 (87.5%) out of 16 
patients took RAA system blockers.
Statistics
The normality of variable distributions was ana-
lyzed using the Shapiro-Wilk test. Homogeneity 
Membrano-
proliferative
 n = 5 (9.4%) 
Focal segmental 
glomerulosclerosis 
n = 3 (5.7%)
 Membranous
nephropathy
n = 10 (18.9%)
Minimal-change 
disease 
n = 8 (15.1%) 
IgA nephropathy 
n = 19 (35.8%) 
Mesangial
proliferative
n = 8 (15.1%)
Non-proliferative glomerulonephritis Proliferative glomerulonephritis
Figure 1. Histopathological findings based on the renal biopsy
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Table I. Right and left kidney length (N = 53)
N Mean ± SD Minimum Maximum
Right kidney length [mm] 53 111.4a ± 12.2 87.0 141.0
Left kidney length [mm] 53 115.4b ± 10.0 98.0 138.0
a, bp = 0.0043
Table II. Absolute renal length and relative renal length indicators (N = 53)
Mean ± SD Minimum Maximum
D [mm]  113.4 ± 10.0 93.5 135.5
D/H [mm/cm]  0.67 ± 0.07 0.52 0.83
D/BSA [mm/m2]  61.8  ± 8.7 47.2 90.6
D/BMI [mm/kg/m2]  4.67 ± 0.79 3.30 6.58
of variance was analyzed using the Levene test. 
For variables with approximately normal distribu-
tions, results were presented as means and standard 
deviations (SDs), and the means were compared 
using the Student’s t-test for independent and 
dependent variables. For variables whose distribu-
tion deviated from normal, results were presented 
as medians and ranges, and significant differen-
ces between groups were determined using the 
Mann-Whitney U test and Wilcoxon test. Group 
proportions were analyzed using the chi-square test 
(c2). Correlations between variables were deter-
mined using the Pearson’s correlation coefficient 
for normally distributed variables and the Spear-
man’s correlation coefficient for non-normally 
distributed variables. 
To find the best parameters and optimal cut-off 
values for treatment efficacy indicators, receiver ope-
rating curves (ROCs) were plotted, and areas un-
der curve (AUC) were calculated. To determine the 
prognostic value of the obtained cut-off values, the 
sensitivity, specificity, positive and negative predic-
tive values, accuracy and likelihood ratio (LR) were 
calculated.
Multiple regression model was used to analyze the 
simultaneous influence of several variables on the 
dependent variable.
The significance level was set at p = 0.05. All cal-
culations were performed using STATISTICA v.10.0 
PL (StatSoft, Inc.).
Results
Ultrasound examination yielded renal length results 
ranging from 87 mm to 141 mm. The mean length 
of the left kidney was statistically significantly greater 
than that of the right kidney (p = 0.0043) (Table I). 
Further analysis focused on the D value, i.e. the 
arithmetic mean of the values of right and left kidney 
length. The values of D and relative renal length ra-
tios D/H, D/BSA, D/BMI for the study population 
are presented in Table II. In the study population, 
no statistically significant correlations were found 
between D and age, H, BSA, or BMI. Mean values of 
right and left kidney length, D and D/H were lower 
in patients with PG (Table III).
In the study population, stage 1–2 CKD was dia-
gnosed in 45 (84.9%) patients at „0”, and in 38 
(71.7%) patients at „24” (Figure 2). At „0”, patients 
with PG were found to have a higher median of 
creatinine levels and a lower mean value of GFR 
MDRD, while patients with NPG were found to 
have a higher median of DPL values. No differences 
were found in the mean values of arterial pressure 
(Table IV).
In the study population, positive correlations were 
found of DPL „0” with D and D/H (Figure 3). 
No statistically significant correlations were found 
of DPL „0” with D/BSA or D/BMI. In patients 
with PG, positive correlations were found of DPL 
„0” with D and D/H, which were not observed in 
patients with NPG (Figures 4, 5).
At „0”, positive correlations were found of DPL 
with SBP (R = 0.53; p = 0.0142) and MAP (R = 
0.48; p = 0.0268) in patients with NPG; such cor-
relations were not found in patients with PG. 
During observation, a decrease in the median of 
DPL values was found in patients from both NPG 
and PG groups. A decrease in mean SBP, DBP and 
MAP values was found only in patients with NPG 
(Tables V, VI).
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Table IV. Clinical characteristics at the beginning of observation depending on the type of glomerulonephritis
PG
(N = 32)
NPG
(N = 21)
p value
Mean ± SD
Median* (min; max)
Mean ± SD
Median* (min; max)
DPL 0 [g/day] 2.12* (0.15; 11.10) 5.45* (0.32; 19.6) 0.0034
Serum creatinine 0 [mg/dL] 0.99* (0.44; 3.56) 0.84* (0.49; 1.42) 0.0090
GFR MDRD 0 [mL/min/1.73 m2]  76.3 ± 28.6  95.2 ± 21.2 0.0124
SBP 0 [mmHg]  125.5 ± 11.6  128.9 ± 14.2 0.3438
DBP 0 [mmHg]  78.5 ± 8.3  82.3 ± 12.0 0.1751
MAP 0 [mmHg]  94.1 ± 8.5  97.8 ± 12.0 0.1979
PP 0 [mmHg]  47.0 ± 9.0  46.6 ± 9.0 0.8708
Table III. Parameters of the kidneys and relative renal length indicators depending on the type of glomerulonephritis
PG
(N = 32)
NPG
(N = 21)
p value
Mean ± SD Mean ± SD
Right kidney length [mm]  107.8 ± 11.6  117.0 ± 11.3 0.0065
Left kidney length [mm]  113.0 ± 9.6  119.1 ± 9.7 0.0272
D [mm]  110.4 ± 9.1  118.0 ± 9.8 0.0056
D/H [mm/cm]  0.65 ± 0.06  0.70 ± 0.07 0.0025
D/BSA [mm/m2]  59.9 ± 7.2  64.6 ± 10.1 0.0538
D/BMI [mm/kg/m2]  4.59 ± 0.76  4.77 ± 0.85 0.4179
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Figure. 2. Percentage of patients in particular CKD stages according to the GFR MDRD at the beginning and at the end of the two-year ob-
servation period
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Figure. 3. Correlations between DPL „0” and D and D/H (N = 53)
Figure 4. Correlations between DPL „0” and D depending on the type of glomerulonephritis
Figure 5. Correlations between DPL „0” and D/H depending on the type of glomerulonephritis
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Table V. Clinical characteristics of the patients with PG at the beginning and at the end of observation (N = 32)
„0” „24” p value
Mean ± SD
Median* (min; max)
Mean ± SD
Median* (min; max)
DPL [g/day] 2.12* (0.15; 11.10) 0.98* (0.00; 5.00) 0.0026
Serum creatinine [mg/dL] 0.99* (0.44; 3.56) 1.01* (0.66; 4.23)# 0.2062
GFR MDRD [mL/min/1.73m2]  76.3 ± 28.6  71.2 ± 24.4# 0.1770
SBP [mmHg]  125.5 ± 11.6  125.5 ± 18.8 0.9905
DBP [mmHg]  78.5 ± 8.3  79.0 ± 10.3 0.7420
MAP [mmHg]  94.1 ± 8.5  94.5 ± 12.7 0.8325
PP [mmHg]  47.0 ± 9.0  46.5 ± 11.0 0.8185
#N = 31
Table VI. Clinical characteristics of the patients with NPG at the beginning and at the end of observation (N = 21)
„0” „24” p value
Mean ± SD
Median* (min; max)
Mean ± SD
Median* (min; max)
DPL [g/day] 5.45* (0.32; 19.6) 1.10* (0.00; 10.2) 0.0030
Serum creatinine [mg/dL] 0.84* (0.49; 1.42) 1.00* (0.60; 1.33) 0.1978
GFR MDRD [mL/min/1.73m2]  95.2 ± 21.2  84.6 ± 20.1 0.0990
SBP [mmHg]  128.9 ± 14.2  119.0 ± 15.3 0.0048
DBP [mmHg]  82.3 ± 12.0  74.3 ± 8.3 0.0035
MAP [mmHg]  97.8 ± 12.0  89.2 ± 9.6 0.0012
PP [mmHg]  46.6 ± 9.0  44.8 ± 11.8 0.5345
R = –0.36     p = 0.0091
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Figure 6. Correlation between DPL changes and D (N = 53)
In the study population, a negative correlation 
was found between DPL changes and D (Figure 
6), whereas no statistically significant correlations 
were found of DPL changes with D/H, D/BSA or 
D/BMI. Negative correlations of DPL changes with 
D, D/H and D/BSA were found only in patients 
with PG (Figure 7).
In the study population, no statistically significant 
correlations were found between DPL changes and 
arterial pressure at the start as well as pressure chang-
es during the observation period. A negative correla-
tion was found between DPL changes and SBP „0” 
only in patients with NPG (Figure 8).
In multiple regression models obtained for all the 
analyzed parameters, only the influence of D on DPL 
changes was statistically significant (Tables VII, VIII).
The criterion for reduced proteinuria was taken 
to be a decrease in DPL after a two-year observation 
period by no less than 50% of the value determined 
at „0”. It was found in 58.5% of the study popula-
tion: 50% of patients with PG and 71.4% of patients 
with NPG; in 51.3% of patients with hypertension 
and 75.0% of patients without hypertension. The 
differences were statistically insignificant.
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Figure 7. Correlations between DPL changes and D, D/H and D/BSA depending on the type of glomerulonephritis
Both in the whole study population and in the 
group of PG patients whose DPL values decreased 
by at least 50%, mean D, D/H and D/BSA values 
were higher (Tables IX, X). The differences were not 
observed in patients with NPG (Table XI).
ROC curves were plotted for all the analyzed pa-
rameters. Cut-off values, differentiating the popu-
lation in terms of the likelihood of DPL decreasing 
by no less than 50%, were determined only for D, 
D/H, D/BSA and DPL „0” (Figure 9). For the said 
arterial hypertension 2018, vol. 22, no. 1
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Figure 8. Correlations between DPL changes and SBP „0” depending on the type of glomerulonephritis
Table VII. Multiple regression analysis for dependent variable DPL 24 — DPL 0 with parameters at the beginning of observation (N = 53)
Dependent variable DPL 24 — DPL 0 [g/day] R2 = 0.172
Independent variable BETA Std. Error BETA p
D [mm] –0.29 0.13 0.0323
SBP 0 [mmHg] –0.23 0.13 0.0818
Table VIII. Multiple regression analysis for dependent variable DPL 24 — DPL 0 with changes of parameters after a two-year observation 
period (N = 52)
Dependent variable DPL 24 — DPL 0 [g/day] R2 = 0.209
Independent variable BETA Std. Error BETA p
D [mm] –0.30 0.13 0.0240
SBP 24 — SBP 0 [mmHg] 0.26 0.13 0.0520
Age [years] –0.14 0.13 0.2850
parameters and their cut-off points, the following 
statistics were calculated: area under curve (AUC), 
sensitivity, specificity, accuracy, positive and negative 
predictive value, and likelihood ratio (LR) (Table XII).
In the study population, no statistically significant 
correlations were found of GFR MDRD „0” and 
GFR MDRD changes with D values and relative 
renal length parameters. None were also found be-
tween GFR MDRD changes and arterial pressure 
at the start as well as pressure changes during the 
observation period.
The criteria for renal function decline were taken 
to be: a double increase in initial serum creatinine 
levels or a decrease in GFR MDRD values by at 
least 4 ml/min/1.73 m2/year or the need to imple-
ment renal replacement therapy during a two-year 
observation period. The said criteria were observed 
in 49.1% of patients from the study population: 
46.9% of patients with PG and 52.4% of patients 
with NPG; 48.6% of patients with hypertension and 
50.0% of patients without hypertension. The differ-
ences were statistically insignificant. In the two-year 
observation period, the median of the value of an-
nual GFR MDRD change was –3.51 mL/min/1.73 
m2/year in the study population, and –10.63 mL/ 
/min/1.73 m2/year in the group of patients with 
renal function decline.
No differences were found in mean values of D, 
relative renal length parameters, and mean values of 
arterial pressure at „0” between patients whose excre-
tory renal function deteriorated and those with no 
renal function decline (data not presented).
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Table IX. Values of absolute renal length and of relative renal length indicators in groups with and without the reduction of DPL by no less 
than 50% during a two-year observation period (N = 53)
With the reduction of DPL by no 
less than 50%
(N = 31)
Without the reduction of DPL 
by no less than 50%
(N = 22)
p value
Mean ± SD Mean ± SD
D [mm] 116.1 ± 8.7 109.7 ± 10.8 0.0181
D/H [mm/cm] 0.69 ± 0.06 0.64 ± 0.06 0.0136
D/BSA [mm/m2] 63.9 ± 9.2 58.8 ± 7.1 0.0336
D/BMI [mm/kg/m2] 4.80 ± 0.90 4.47 ± 0.6 0.3111
Table X. Values of absolute renal length and of relative renal length indicators in groups with and without the reduction of DPL by no less 
than 50% during a two-year observation period in patients with PG (N = 32)
With the reduction of DPL by no 
less than 50%
(N = 16)
Without the reduction of DPL 
by no less than 50%
(N = 16)
p value
Mean ± SD Mean ± SD
D [mm] 114.1 ± 8.2 106.7 ± 8.7 0.0187
D/H [mm/cm] 0.67 ± 0.05 0.62 ± 0.05 0.0081
D/BSA [mm/m2] 6.6 ± 6.5 57.2 ± 7.0 0.0305
D/BMI [mm/kg/m2] 4.76 ± 0.85 4.43 ± 0.64 0.2185
Table XI. Values of absolute renal length and of relative renal length indicators in groups with and without the reduction of DPL by no less 
than 50% during a two-year observation period in patients with NPG (N = 21)
With the reduction of DPL by no 
less than 50%
(N = 15)
Without the reduction of DPL 
by no less than 50%
(N = 6)
p value
Mean ± SD Mean ± SD
D [mm] 118.3 ± 8.9 117.4 ± 12.7 0.2701
D/H [mm/cm] 0.70 ± 0.07 0.70 ± 0.07 1.0000
D/BSA [mm/m2] 65.3 ± 11.5 63.0 ± 5.9 0.1455
D/BMI [mm/kg/m2] 4.85 ± 0.96 4.59± 0.45 0.1023
Table XII. Determination of predictive values for the reduction of DPL by no less than 50% during a two-year observation period at determi-
ned cut-off values
Parameter Cut-off value AUC Sensitivity Specificity Accuracy Positive 
predictive 
value
Negative 
predictive value
LR
D [mm] 106.0 0.698 0.935 0.455 0.736 0.710 0.833 1.7
D/H [mm/cm] 0.64 0.707 0.806 0.600 0.720 0.735 0.684 2.0
D/BSA [mm/m2] 60.92 0.658 0.613 0.682 0.640 0.731 0.555 1.9
DPL 0 [g/day] 4.50 0.790 0.613 0.910 0.740 0.905 0.625 6.7
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Figure 9. ROC curves for D, D/H, D/BSA and DPL „0” presenting cut-off values for the DPL reduction by no less than 50% during a two-year 
observation period
ROC curves were also plotted for the above pa-
rameters, though they did not differentiate the study 
population in terms of the risk for excretory renal 
function decline (data not presented).
Discussion
Renal length measurements obtained in patients with 
primary, chronic glomerulopathies, the broad range 
of their values and interrelations between left and 
right kidney length (Tables I–III) are consistent with 
results obtained in studies involving populations of 
patients with no diagnosis of a present or past kidney 
disease [8, 14, 15].
In the present study, relative renal length indica-
tors were calculated and presented in Tables II and III. 
In a study by Mileticia et al., an attempt was also 
made to examine the correlation between kidney 
length and height. Right and left kidney lengths 
were related to height and the KBR parameter (kid-
ney length/body height ratio) was calculated, corre-
sponding to the D/H parameter used in the present 
study. In a group of patients aged 20–59 — an age 
range similar to that in the present study — mean 
KBR values were 0.672–0.664 mm/cm for the left 
and 0.661–0.647 mm/cm for the right kidney [16]. 
The values were thus comparable to mean D/H 
values obtained in the present study. The literature 
lacks data on value ranges for the remaining relative 
renal length ratios (D/BSA and D/BMI), both in 
healthy adults and in patients with chronic kidney 
disease.
In the study population, no statistically significant 
correlations were found of D with H, BSA or BMI. 
Numerous studies have reported such correlations, 
though they were of moderate or low significance, 
which suggests the need to critically reconsider the 
said correlations [14, 17]. In the study population, 
no correlations were also found between D values 
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and age, which is understandable considering the 
age of subjects included in the study and the fact that 
renal length remains constant between age 30–60 
and can be expected to decrease in patients aged over 
60–70 [14, 15, 18].
Analysis of differences in renal length parameters 
(Table III) and renal excretory functions at the be-
ginning of observation (Table IV) between patients 
with PG and those with NPG allows to assume that 
the level of progression of tubulointerstitial chang-
es determining the functional status and structural 
changes of the kidneys in patients with PG could 
be higher. PG is more often associated with low-
er proteinuria, active urinary sediment and arterial 
hypertension (often incorrectly diagnosed as prima-
ry hypertension). These are indicators of nephritic 
syndrome, which is presumably identified later than 
nephrotic syndrome — a common indicator of NPG 
— which in turn might promote the progression of 
tubulointerstitial changes.
As regards the influence of arterial hypertension 
and its changes on changes in proteinuria and GFR, 
the present findings are unlike those revealed by many 
studies which observed significant correlations be-
tween hypertension, proteinuria and GFR [19–22]. 
A likely cause of the discrepancies is the fact that 
despite the high rate of diagnosis of hypertension, 
the values of arterial blood pressure remained rela-
tively low both at the start and during the two-year 
observation period (Tables IV–VI). This might be 
the result of the intensive pharmacotherapy admin-
istered (including RAA blockers), allowing to achieve 
the lowest pressure values which were well tolerated 
by patients, but consequently precluding the pos-
sibility to determine a possible influence of arterial 
pressure on changes in proteinuria and GFR. Since 
the course of arterial hypertension accompanying 
glomerulonephritis is characterized by complex in-
terrelations between systemic arterial pressure and 
hemodynamic conditions within renal glomeruli, 
damage to glomerular structures caused by hyper-
filtration, hyperperfusion and barotrauma might be 
largely unaffected by the value of systemic pressure. 
Analysis of pressure changes and its correlations with 
changes in proteinuria allows to assume that the 
role of systemic systolic blood pressure in inducing 
proteinuria changes is most significant in patients 
with NPG (Figure 8), which might be associated 
with a different pathogenesis of glomerular changes 
depending on the type of glomerulopathy, including 
the active role of podocytes and mesangiocytes in the 
inflammatory process, the autoregulation of blood 
flow, and the degree of transmission of systemic pres-
sure onto glomerular circulation [23, 24].
Proteinuria and its changes, serving as an indica-
tor of treatment efficacy, seem to be connected with 
renal length (Tables VII–X; Figures 3–7, 9). Analysis 
of ROC curves allowed to determine the values of D, 
D/H and D/BSA, which best divide the study pop-
ulation into a sub-group with a higher likelihood of 
DPL decreasing by at least 50%, and a sub-group in 
which the said likelihood is lower. The highest AUC 
values reaching 0.698 and 0.707 were observed for 
D and D/H, respectively. For D and D/H, relatively 
high values of sensitivity were also observed, stand-
ing at 0.935 and 0.806, at specificity of 0.455 and 
0.600, and accuracy of 0.736 and 0.720. AUC value, 
sensitivity and accuracy for D/BSA were lower, and 
the specificity was 0.682. The positive predictive 
value for all three kidney size parameters was similar 
and ranged from 0.710 to 0.735, which means that 
in 71.0% of patients with D ≥ 106 mm, in 73.5% 
with D/H ≥ 0.64 mm/cm and in 73.1% with D/BSA 
≥ 60.92 mm/m2, DPL value decreased by at least 
50% during the two-year observation period 
(Table XII). The obtained results might indicate that 
as the value of renal length increases, the level of 
DPL at the beginning of observation increases as 
well, but so also does the likelihood of its reduction 
during the two-year observation period. It also seems 
that the type of glomerulopathy might determine the 
correlations between proteinuria and its changes, and 
renal length (Tables X, XI; Figure 7). Further studies 
are required to verify the above observations.
The most significant changes in renal length are 
found at GFR 30–90 mL/min, which suggests that 
processes leading to structural changes are most nu-
merous in CKD stage 2 and 3 [11]. The rate of 
glomerular filtration defect might inversely affect 
the reduction of renal length [25]. Considering the 
above, it might be assumed that the high percentage 
of patients remaining in stage 1–2 of CKD (Figure 2) 
and the severe dynamics of GFR MDRD defect 
could account for the lack of correlations of GFR 
MDRD at the beginning of the two-year observa-
tion and its changes during that period with renal 
length. Additional information could be provided by 
sequential measurements of renal length performed 
during a longer period of observation.
Conclusions
Renal length of adult patients with primary, chron-
ic glomerulonephritis in the early stages of chronic 
kidney disease and with normal or slightly decreased 
glomerular filtration rate is comparable to renal 
length in healthy people.
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No influence of arterial blood pressure and its 
changes on the efficacy of treatment was discovered. 
Renal length does not constitute a prognostic fac-
tor for changes in glomerular filtration rate; however, 
it can be a prognostic factor for proteinuria changes, 
particularly in patients with proliferative glomerulo-
nephritis. The highest prognostic value is displayed 
by absolute renal length and relative renal length 
measurements D/H and D/BSA.
Renal length was not found to be a factor modi-
fying the influence of arterial blood pressure and its 
changes on treatment efficacy.
Influence of arterial blood pressure and renal 
length on treatment efficacy may depend on the type 
of glomerulonephritis.
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